602 related articles for article (PubMed ID: 22858080)
1. The impact of heart failure on the classification of COPD severity.
Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
[TBL] [Abstract][Full Text] [Related]
2. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
Maskey-Warzechowska M; Pankowska M; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
[TBL] [Abstract][Full Text] [Related]
3. COPD in chronic heart failure: less common than previously thought?
Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
[TBL] [Abstract][Full Text] [Related]
4. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
[TBL] [Abstract][Full Text] [Related]
5. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
6. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
[TBL] [Abstract][Full Text] [Related]
7. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
9. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
Checkley W; Foreman MG; Bhatt SP; Dransfield MT; Han M; Hanania NA; Hansel NN; Regan EA; Wise RA;
Respir Med; 2016 Feb; 111():30-8. PubMed ID: 26712569
[TBL] [Abstract][Full Text] [Related]
10. Post-bronchodilator spirometry reference values in adults and implications for disease management.
Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
Chhabra SK; Bhatnagar S
Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
[TBL] [Abstract][Full Text] [Related]
12. Impact of direct substitution of arm span length for current standing height in elderly COPD.
Pothirat C; Chaiwong W; Phetsuk N
Int J Chron Obstruct Pulmon Dis; 2015; 10():1173-8. PubMed ID: 26150709
[TBL] [Abstract][Full Text] [Related]
13. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
[TBL] [Abstract][Full Text] [Related]
14. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers.
Akkermans RP; Biermans M; Robberts B; ter Riet G; Jacobs A; van Weel C; Wensing M; Schermer T
Eur Respir J; 2014 Jan; 43(1):54-63. PubMed ID: 23563262
[TBL] [Abstract][Full Text] [Related]
15. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
[TBL] [Abstract][Full Text] [Related]
16. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
Richter DC; Joubert JR; Nell H; Schuurmans MM; Irusen EM
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):693-9. PubMed ID: 19281083
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
[TBL] [Abstract][Full Text] [Related]
19. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
[TBL] [Abstract][Full Text] [Related]
20. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
